With respect to hormone-receptor positive breast cancer (i.e. particularly histological invasive lobular and intrinsic luminal breast carcinoma) these data underline a tumor suppressive role of NDRG2 probably depending on positive hormone-receptor expression. This evidence concerns the gene NDRG2 and neoplasm.